Cargando…
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
Prostate cancer (PCa) is the most widely diagnosed male cancer in the Western World and while low- and intermediate-risk PCa patients have a variety of treatment options, metastatic patients are limited to androgen deprivation therapy (ADT). This treatment paradigm has been in place for 75 years due...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325456/ https://www.ncbi.nlm.nih.gov/pubmed/27487144 http://dx.doi.org/10.18632/oncotarget.10901 |